Specialty chemicals drove Q1 2025 growth with higher EBITDA and margin, offsetting declines in basics and intermediates. Major investments and customer prepayments strengthened cash flow, and full-year guidance for record sales and EBITDA is confirmed.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.